taxonomy (4)
protein (12)
source (8)
structure (4)
composition (1)
disease (3)
reference (10)
site (27)
peptide (62)
- Homo sapiens (Human)
- Mesocricetus auratus (Golden hamster)
- Rattus norvegicus (Norway rat)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- 4F2 cell-surface antigen heavy chain / Homo sapiens P08195
- Bone marrow stromal antigen 2 / Homo sapiens Q10589
- CD59 glycoprotein / Homo sapiens P13987
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens Q9Y5L3
- Erythropoietin / Homo sapiens P01588
- Intercellular adhesion molecule-3 (CD50) / Homo sapiens P32942
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens Q9BYF1
- Uromodulin / Homo sapiens P07911
- Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Kidney (UBERON_0002113) BHK-21 (CVCL_1914)
- Kidney (UBERON_0002113) BHK-21 (CVCL_1914) Plasma Membrane (GO_0005886)
- Kidney (UBERON_0002113) BHK21/13/Py6 (CVCL_LM74) Plasma Membrane (GO_0005886)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- 3Y1-B clone 1 (CVCL_4563)
- HEK293 (CVCL_0045)
- T-Lymphocyte (CL_0000084)
Source
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 3 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 3 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 4 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
Reported structure
- Hex:10 HexNAc:9 dHex:1 (avg mass : 3614.3373 )
Composition
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Structural study of N-linked oligosaccharides of human intercellular adhesion molecule-3 (CD50). (2001 - Funatsu O, Sato T, Kotovuori P, Gahmberg CG, Ikekita M, Furukawa K) / Status : Reviewed
- Biological and physicochemical characterization of recombinant human erythropoietins fractionated by Mono Q column chromatography and their modification with sialyltransferase. (1996 - Morimoto K, Tsuda E, Said A, Uchida E, Hatakeyama S, Ueda M, Hayakawa T) / Status : Reviewed
- Transfection with fragments of the adenovirus 12 gene induces tumorigenicity-associated alteration of N-linked sugar chains in rat cells. (1990 - Hiraizumi S, Takasaki S, Shiroki K, Kochibe N, Kobata A) / Status : Reviewed
- Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietins. (1988 - Tsuda E, Goto M, Murakami A, Akai K, Ueda M, Kawanishi G, Takahashi N, Sasaki R, Chiba H, Ishihara H) / Status : Reviewed
- Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. (1984 - Yamashita K, Ohkura T, Tachibana Y, Takasaki S, Kobata A) / Status : Reviewed
Reference
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Bone marrow stromal antigen 2 / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens
-
Erythropoietin / Homo sapiens
- Undefined site
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens
- Uromodulin / Homo sapiens
-
Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Undefined site
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- TAVNCSSDFDACLITK (16aa)
- NVTHIIQQEITEAQK (15aa)
- NLTVK (5aa)
- GWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPF (38aa)
- TQSLLIVNNATNVVIKVCEF (20aa)
- SNIIRGWIFGTTLDSKTQSLLIVNNATNVVIK (32aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPF (28aa)
- NNKSWMESEFRVYSSANNCTF (21aa)
- NNKSWMESEFRVYSSANNCTFEYVS (25aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLM (30aa)
- NNKSWMESEFRVYSSANNCTFEYV (24aa)
- NNKSWMESEFRVYSSANNCTFEYVSQ (26aa)
- NNKSWMESEFRVYSSANNCT (20aa)
- NNKSWMESEFRVYSSANNCT (20aa)
- NNKSWMESEFRVYSSANNCTFEY (23aa)
- NNKSWMESEFRVYSSANN (18aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLMD (31aa)
- VYSSANNCTF (10aa)
- YNENGTITDAVDC (13aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCAL (15aa)
- GFSTQVLLGDVYQSPCTMAQRPQNFNSSAR (30aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- PTESIVRFPNITNLCPFGEVFNATR (25aa)
- NITNLCPFGEVFNATRFASVYAWNR (25aa)
- FPNITNLCPFGEVFNATRFASVYAWN (26aa)
- FPNITNLCPFGEVFNATRFA (20aa)
- FPNITNLCPFGEVFNAT (17aa)
- IVRFPNITNLCPFGEVFNATR (21aa)
- VQPTESIVRFPNITNLCPFGEVFNA (25aa)
- IVRFPNITNLCPFGEVFNATRFASVYAWNR (30aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- PGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (35aa)
- VYSTGSNVFQTRAGCLIGAEHVNNSYEC (28aa)
- AGCLIGAEHVNNSYECDIPIG (21aa)
- NNSIAIPTNFTISVTTEILPVSMTK (25aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEI (36aa)
- IIAYTMSLGAENSVAYSNNSIAIPT (25aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNF (28aa)
- ENSVAYSNNSIAIPTNFTISVTTEILPVSMTK (32aa)
- NSVAYSNNSIAIPTNFTISVTTEILPVSMTK (31aa)
- DFGGFNFSQILPDPS (15aa)
- NFTTAPAI (8aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNC (35aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPE (53aa)
- EGVFVSNGTHWF (12aa)
- AHFPREGVFVSNGTHWFVTQRNFYEPQIITT (31aa)
- YFKNHTSPDVDLGDISGINASVVN (24aa)
- NHTSPDVDLGDISGINASVVNIQKEIDRLN (30aa)
- YFKNHTSPDVDLGDISGINAS (21aa)
- NHTSPDVDLGDISGINASVVNIQKEIDR (28aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- YFKNHTSPDVDL (12aa)
- YFKNHTSPDVDLGDISGINASVVNI (25aa)
- NHTSPDVDLGDISGINASVVNIQ (23aa)
- YFKNHTSPDVDLGDISGINASVVNIQ (26aa)
- YFKNHTSPDVDLGDISGIN (19aa)
- YFKNHTSPDVDLGDISGIN (19aa)
- NHTSPDVDLGDISGIN (16aa)
- NHTSPDVDLGDISGIN (16aa)
- NHTSPDVDLGDISGINASVVN (21aa)
- NHTSPDVDLGDISGINASVVN (21aa)
- NLNESLIDLQEL (12aa)
- NLNESLIDLQELG (13aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 3614.3373)
- Kidney (UBERON_0002113) BHK-21 (CVCL_1914) Plasma Membrane (GO_0005886)
- Kidney (UBERON_0002113) BHK21/13/Py6 (CVCL_LM74) Plasma Membrane (GO_0005886)
- 3Y1-B clone 1 (CVCL_4563)
- Transfection with fragments of the adenovirus 12 gene induces tumorigenicity-associated alteration of N-linked sugar chains in rat cells. (1990 - Hiraizumi S, Takasaki S, Shiroki K, Kochibe N, Kobata A) / Status : Reviewed
- Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. (1984 - Yamashita K, Ohkura T, Tachibana Y, Takasaki S, Kobata A) / Status : Reviewed
-
Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Undefined site
-
Uncharacterized protein from Undefined tissue / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex (avg mass : 3614.3373)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 3614.3373)
- Kidney (UBERON_0002113) BHK-21 (CVCL_1914) Plasma Membrane (GO_0005886)
- Kidney (UBERON_0002113) BHK21/13/Py6 (CVCL_LM74) Plasma Membrane (GO_0005886)
-
- N-Linked / Complex (avg mass : 3614.3373)
- Kidney (UBERON_0002113) BHK-21 (CVCL_1914)
- Biological and physicochemical characterization of recombinant human erythropoietins fractionated by Mono Q column chromatography and their modification with sialyltransferase. (1996 - Morimoto K, Tsuda E, Said A, Uchida E, Hatakeyama S, Ueda M, Hayakawa T) / Status : Reviewed
- Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietins. (1988 - Tsuda E, Goto M, Murakami A, Akai K, Ueda M, Kawanishi G, Takahashi N, Sasaki R, Chiba H, Ishihara H) / Status : Reviewed
-
Erythropoietin / Homo sapiens
- Undefined site
-
- Hex:10 HexNAc:9 dHex:1 / N-Linked (avg mass : 3614.3373)
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 3 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 3 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 4 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Bone marrow stromal antigen 2 / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens
- Uromodulin / Homo sapiens
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TAVNCSSDFDACLITK (16aa)
- NVTHIIQQEITEAQK (15aa)
- NLTVK (5aa)
- GWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPF (38aa)
- TQSLLIVNNATNVVIKVCEF (20aa)
- SNIIRGWIFGTTLDSKTQSLLIVNNATNVVIK (32aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPF (28aa)
- NNKSWMESEFRVYSSANNCTF (21aa)
- NNKSWMESEFRVYSSANNCTFEYVS (25aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLM (30aa)
- NNKSWMESEFRVYSSANNCTFEYV (24aa)
- NNKSWMESEFRVYSSANNCTFEYVSQ (26aa)
- NNKSWMESEFRVYSSANNCT (20aa)
- NNKSWMESEFRVYSSANNCT (20aa)
- NNKSWMESEFRVYSSANNCTFEY (23aa)
- NNKSWMESEFRVYSSANN (18aa)
- NNKSWMESEFRVYSSANNCTFEYVSQPFLMD (31aa)
- VYSSANNCTF (10aa)
- YNENGTITDAVDC (13aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCAL (15aa)
- GFSTQVLLGDVYQSPCTMAQRPQNFNSSAR (30aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- PTESIVRFPNITNLCPFGEVFNATR (25aa)
- NITNLCPFGEVFNATRFASVYAWNR (25aa)
- FPNITNLCPFGEVFNATRFASVYAWN (26aa)
- FPNITNLCPFGEVFNATRFA (20aa)
- FPNITNLCPFGEVFNAT (17aa)
- IVRFPNITNLCPFGEVFNATR (21aa)
- VQPTESIVRFPNITNLCPFGEVFNA (25aa)
- IVRFPNITNLCPFGEVFNATRFASVYAWNR (30aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- PGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (35aa)
- VYSTGSNVFQTRAGCLIGAEHVNNSYEC (28aa)
- AGCLIGAEHVNNSYECDIPIG (21aa)
- NNSIAIPTNFTISVTTEILPVSMTK (25aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEI (36aa)
- IIAYTMSLGAENSVAYSNNSIAIPT (25aa)
- SIIAYTMSLGAENSVAYSNNSIAIPTNF (28aa)
- ENSVAYSNNSIAIPTNFTISVTTEILPVSMTK (32aa)
- NSVAYSNNSIAIPTNFTISVTTEILPVSMTK (31aa)
- DFGGFNFSQILPDPS (15aa)
- NFTTAPAI (8aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNC (35aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPE (53aa)
- EGVFVSNGTHWF (12aa)
- AHFPREGVFVSNGTHWFVTQRNFYEPQIITT (31aa)
- YFKNHTSPDVDLGDISGINASVVN (24aa)
- NHTSPDVDLGDISGINASVVNIQKEIDRLN (30aa)
- YFKNHTSPDVDLGDISGINAS (21aa)
- NHTSPDVDLGDISGINASVVNIQKEIDR (28aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- YFKNHTSPDVDL (12aa)
- YFKNHTSPDVDLGDISGINASVVNI (25aa)
- NHTSPDVDLGDISGINASVVNIQ (23aa)
- YFKNHTSPDVDLGDISGINASVVNIQ (26aa)
- YFKNHTSPDVDLGDISGIN (19aa)
- YFKNHTSPDVDLGDISGIN (19aa)
- NHTSPDVDLGDISGIN (16aa)
- NHTSPDVDLGDISGIN (16aa)
- NHTSPDVDLGDISGINASVVN (21aa)
- NHTSPDVDLGDISGINASVVN (21aa)
- NLNESLIDLQEL (12aa)
- NLNESLIDLQELG (13aa)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reference
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reference
Reported glycosite
